Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202) | Zendy

Xiang Wang | Zendy; Diansheng Zhong | Zendy; Junping Zhang | Zendy; Nan Du | Zendy; Yuchuan Ren | Zendy; Jinghua Gao | Zendy; Likun Liu | Zendy; Junyan Yu | Zendy; Xiaomei Li | Zendy; Liwen Ma | Zendy; Aimin Zang | Zendy; Mudan Yang | Zendy; Yan Zhang | Zendy; Jun Guo | Zendy; Zheng Liu | Zendy; Zhanzhao Fu | Zendy; Junmei Jia | Zendy; Jianfeng Diao | Zendy; Zaiwen Fan | Zendy; Xiang Song | Zendy; Guozhong Li | Zendy; Huaqing Wang | Zendy; Chunmei Bai | Zendy; Mei Guan | Zendy; Xiubao Ren | Zendy; Ruixing Zhang | Zendy

Open Access

Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202)

Author(s) -

Xiang Wang,

Diansheng Zhong,

Junping Zhang,

Nan Du,

Yuchuan Ren,

Jinghua Gao,

Likun Liu,

Junyan Yu,

Xiaomei Li,

Liwen Ma,

Aimin Zang,

Mudan Yang,

Yan Zhang,

Jun Guo,

Zheng Liu,

Zhanzhao Fu,

Junmei Jia,

Jianfeng Diao,

Zaiwen Fan,

Xiang Song,

Guozhong Li,

Huaqing Wang,

Chunmei Bai,

Mei Guan,

Xiubao Ren,

Ruixing Zhang

Publication year - 2022

Publication title -

journal of gastrointestinal oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.084

H-Index - 39

eISSN - 2219-679X

pISSN - 2078-6891

DOI - 10.21037/jgo-22-727

Subject(s) - apatinib , medicine , adverse effect , clinical endpoint , cancer , population , dosing , clinical trial , surgery , gastroenterology , oncology , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research